Annovis Bio, Inc. (ANVS) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
ANVS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ANVS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export ANVS earnings history in CSV or JSON format
Free sign-in required to download data
Annovis Bio, Inc. (ANVS) Earnings Overview
As of May 8, 2026, Annovis Bio, Inc. (ANVS) reported trailing twelve-month net income of -$29M, reflecting +99.9% year-over-year growth. The company earned $-1.16 per diluted share over the past four quarters.
Looking at the long-term picture, ANVS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$682,000 in fiscal 2017.
Annovis Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SAVA (-$106M net income), PRTA (-$151M net income, -2520.6% margin), ACAD ($376M net income, 36.5% margin), ANVS has comparable earnings metrics. Compare ANVS vs SAVA →
ANVS Earnings vs Peers
Earnings metrics vs comparable public companies
ANVS Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$29M | -17.3% | -$30M | $-1.40 | - | - |
| 2024 | -$25M | +56.2% | -$27M | $-2009.77 | - | - |
| 2023 | -$56M | -121.9% | -$45M | $-6.23 | - | - |
| 2022 | -$25M | -74.8% | -$26M | $-3.10 | - | - |
| 2021 | -$14M | -165.2% | -$15M | $-1.90 | - | - |
| 2020 | -$5M | -451.2% | -$7M | $-0.87 | - | - |
| 2019 | $-991,000 | -38.8% | -$2M | $-0.17 | - | - |
| 2018 | $-714,000 | -4.7% | $-714,000 | $-0.16 | - | - |
| 2017 | $-682,000 | - | $-682,000 | $-0.16 | - | - |
See ANVS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ANVS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ANVS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonANVS — Frequently Asked Questions
Quick answers to the most common questions about buying ANVS stock.
Is ANVS growing earnings?
ANVS EPS is $-1.16, with earnings growth accelerating to +99.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-29M.
What are ANVS's profit margins?
Annovis Bio, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ANVS's earnings?
ANVS earnings data spans 2017-2025. The accelerating earnings trend is +99.9% YoY. Historical data enables comparison across business cycles.